Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Evaluation of the safety and efficacy of esophagojejunostomy after totally laparoscopic total gastrectomy using a trans-orally inserted anvil: a single-center comparative study.

Ito H, Inoue H, Odaka N, Satodate H, Onimaru M, Ikeda H, Takayanagi D, Nakahara K, Kudo SE.

Surg Endosc. 2014 Jun;28(6):1929-35. doi: 10.1007/s00464-014-3417-x. Epub 2014 Feb 1.

PMID:
24488351
2.

[Full-layer resection of the gastric wall, focusing on the "nonexposure technique"].

Inoue H, Ikeda H, Onimaru M, Sato C, Odaka N, Itoh H, Kudo SE.

Nihon Geka Gakkai Zasshi. 2013 Nov;114(6):321-6. Japanese.

PMID:
24358729
3.

Surgical outcomes and clinicopathological characteristics of patients who underwent potentially noncurative endoscopic resection for gastric cancer: a report of a single-center experience.

Ito H, Inoue H, Ikeda H, Odaka N, Yoshida A, Satodate H, Onimaru M, Takayanagi D, Santi EG, Kudo SE.

Gastroenterol Res Pract. 2013;2013:427405. doi: 10.1155/2013/427405. Epub 2013 May 16.

4.

Comparison of Clinicopathological Characteristics in the Patients with Cardiac Cancer with or without Esophagogastric Junctional Invasion: A Single-Center Retrospective Cohort Study.

Ito H, Inoue H, Odaka N, Satodate H, Suzuki M, Mukai S, Takehara Y, Omoto T, Kudo SE.

Int J Surg Oncol. 2013;2013:189459. doi: 10.1155/2013/189459. Epub 2013 Jan 10.

5.

Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study.

Ito H, Inoue H, Odaka N, Satodate H, Suzuki M, Mukai S, Takehara Y, Kida H, Kudo SE.

J Exp Clin Cancer Res. 2013 Jan 7;32:2. doi: 10.1186/1756-9966-32-2.

6.

Prognostic impact of prophylactic splenectomy for upper-third gastric cancer: a cohort study.

Ito H, Inoue H, Odaka N, Satodate H, Mukai S, Omoto T, Takehara Y, Kudo SE.

Anticancer Res. 2013 Jan;33(1):277-82.

PMID:
23267157
7.

Fine-needle aspiration biopsy and endoscopic ultrasound for pretreatment pathological diagnosis of gastric gastrointestinal stromal tumors.

Ito H, Inoue H, Ryozawa S, Ikeda H, Odaka N, Eleftheriadis N, Maselli R, Sando N, Kimura S, Kudo SE.

Gastroenterol Res Pract. 2012;2012:139083. doi: 10.1155/2012/139083. Epub 2012 Sep 26.

8.

Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study.

Ito H, Inoue H, Sando N, Kimura S, Gohda K, Sato J, Murakami K, Ito S, Odaka N, Satodate H, Kudo SE.

BMC Cancer. 2012 Aug 9;12:346. doi: 10.1186/1471-2407-12-346.

9.

[Prone esophagectomy with ropeway technique intending complete lymph node dissection of the mediastinum with thoracic duct excision for esophageal squamous cell carcinoma].

Inoue H, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo SE.

Nihon Rinsho. 2011 Aug;69 Suppl 6:298-305. Japanese. No abstract available.

PMID:
22471034
10.

Peroral endoscopic myotomy (POEM) for esophageal achalasia.

Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S.

Endoscopy. 2010 Apr;42(4):265-71. doi: 10.1055/s-0029-1244080. Epub 2010 Mar 30.

PMID:
20354937
11.

Endoscopic mucosal resection for early-stage gastrointestinal cancers.

Inoue H, Sato Y, Sugaya S, Inui M, Odaka N, Satodate H, Kudo SE.

Best Pract Res Clin Gastroenterol. 2005 Dec;19(6):871-87. Review. No abstract available.

PMID:
16338647
12.

[A case of effective treatment of oral TS-1 and intravenous MMC administration for multiple metastases of gastric cancer].

Katsumata D, Sasaki K, Miyachi K, Joujima T, Tsumuraya M, Onodera S, Shimoda W, Yoda N, Ohkawa T, Odaka N, Kaneko H, Sunagawa M.

Gan To Kagaku Ryoho. 2004 Jul;31(7):1083-5. Japanese.

PMID:
15272590
13.
14.

International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines.

Mellemgaard A, Lindblad P, Schlehofer B, Bergström R, Mandel JS, McCredie M, McLaughlin JK, Niwa S, Odaka N, Pommer W, et al.

Int J Cancer. 1995 Jan 27;60(3):350-4.

PMID:
7829243
15.

A comparison of risk factors for human immunodeficiency virus and hepatitis B virus infections in homosexual men.

Koziol DE, Saah AJ, Odaka N, Muñoz A.

Ann Epidemiol. 1993 Jul;3(4):434-41.

PMID:
8275222
16.

Assessment of the antibody response to the immunosuppressive/immunodominant region of HIV gp41 in a 5-year longitudinal study.

Monell CR, Hoover DR, Odaka N, He X, Saah AJ, Strand M.

J Med Virol. 1993 Feb;39(2):125-30.

PMID:
8487036
17.

High socioeconomic status is a risk factor for human immunodeficiency virus type 1 (HIV-1) infection but not for sexually transmitted diseases in women in Malawi: implications for HIV-1 control.

Dallabetta GA, Miotti PG, Chiphangwi JD, Saah AJ, Liomba G, Odaka N, Sungani F, Hoover DR.

J Infect Dis. 1993 Jan;167(1):36-42.

PMID:
8418181
18.

Longitudinal study of homosexual couples discordant for HIV-1 antibodies in the Baltimore MACS Study.

Palenicek J, Fox R, Margolick J, Farzadegan H, Hoover D, Odaka N, Rubb S, Armenian H, Harris J, Saah AJ.

J Acquir Immune Defic Syndr. 1992 Dec;5(12):1204-11.

PMID:
1453331
19.

Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time.

Farzadegan H, Chmiel JS, Odaka N, Ward L, Poggensee L, Saah A, Phair JP.

J Infect Dis. 1992 Dec;166(6):1217-22.

PMID:
1358985
20.

The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort Study.

Hoover DR, Muñoz A, Carey V, Odaka N, Taylor JM, Chmiel JS, Armstrong J, Vermund SH.

Stat Med. 1991 Dec;10(12):1993-2003.

PMID:
1805323
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk